Media Publications - Critical Path Institute

December 10, 2024

Biomarkers 101: A Patient’s Perspective on the Importance of Identifying New Biomarkers

Biomarkers are emerging as powerful tools in the field of kidney health, playing a crucial role in the diagnosis, monitoring...

November 27, 2024

Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...

November 27, 2024

C-Path CEO Klaus Romero and President & COO Kristen Swingle, President and COO were recently named to the 100 Most...

December 12, 2024

Join us for the webinar, "The Power of Data Sharing and Collaboration Across LGMDs in a Pre-Competitive, Neutral Environment."

November 19, 2024

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accele

November 17, 2024

On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize...

November 14, 2024

In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium

November 13, 2024

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..

November 7, 2024

Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.

April 9, 2025-April 10, 2025

On April 9-10, 2025, the 2025 Clinical Outcome Assessment...